ArticlePDF Available

Intake and sources of gluten in 20- to 75-year-old Danish adults: a national dietary survey

Authors:

Abstract and Figures

Purpose: Celiac disease, an immunological response triggered by gluten, affects ~1 % of the Western population. Information concerning gluten intake in the general population is scarce. We determined intake of gluten from wheat, barley, rye and oat in the Danish National Survey of Diet and Physical Activity 2005-2008. The study population comprised a random cross-sectional sample of 1494 adults 20-75 years, selected from the Danish Civil Registration System. Methods: Protein content in wheat, rye, barley and oat was determined from the National Danish Food Composition Table and multiplied with the amount of cereal used in recipes. Amount of gluten was calculated as amount of cereal protein ×0.80 for wheat and oat, ×0.65 for rye and ×0.50 for barley. Dietary intake was recorded daily during seven consecutive days in pre-coded food diaries with open-answer possibilities. Results: Mean total gluten intake was 10.4 ± 4.4 g/day (10th-90th percentiles; 5.4-16.2 g/day), in men 12.0 ± 4.6 g/day and 9.0 ± 3.4 g/day in women. It was higher among men than among women in all age groups (20-75 years; P < 0.0001); however, this difference was eliminated when adjusting for energy intake. Intake of different gluten sources tended to be higher in men than in women with the exception of gluten from barley. Total gluten intake decreased with increasing age (P < 0.0001) as did gluten intake from wheat (P < 0.0001), whereas intake of gluten from rye (P < 0.0001) and barley (P = 0.001) increased with increasing age, also when adjusted for energy intake or body weight. Conclusion: This study presents representative population-based data on gluten intake in Danish adults. Total gluten intake decreased with increasing age.
This content is subject to copyright. Terms and conditions apply.
1 3
Eur J Nutr
DOI 10.1007/s00394-015-1062-3
ORIGINAL CONTRIBUTION
Intake and sources of gluten in 20‑ to 75‑year‑old Danish adults: a
national dietary survey
Camilla Hoppe1 · Rikke Gøbel2 · Mette Kristensen3 · Mads Vendelbo Lind4,5 ·
Jeppe Matthiessen1 · Tue Christensen1 · Ellen Trolle1 · Sisse Fagt1 ·
Mia Linda Madsen2 · Steffen Husby5
Received: 18 December 2014 / Accepted: 25 September 2015
© Springer-Verlag Berlin Heidelberg 2015
×0.50 for barley. Dietary intake was recorded daily dur-
ing seven consecutive days in pre-coded food diaries with
open-answer possibilities.
Results Mean total gluten intake was 10.4 ± 4.4 g/
day (10th–90th percentiles; 5.4–16.2 g/day), in men
12.0 ± 4.6 g/day and 9.0 ± 3.4 g/day in women. It was
higher among men than among women in all age groups
(20–75 years; P < 0.0001); however, this difference was
eliminated when adjusting for energy intake. Intake of dif-
ferent gluten sources tended to be higher in men than in
women with the exception of gluten from barley. Total glu-
ten intake decreased with increasing age (P < 0.0001) as
did gluten intake from wheat (P < 0.0001), whereas intake
of gluten from rye (P < 0.0001) and barley (P = 0.001)
increased with increasing age, also when adjusted for
energy intake or body weight.
Conclusion This study presents representative popula-
tion-based data on gluten intake in Danish adults. Total glu-
ten intake decreased with increasing age.
Keywords Gluten · Wheat · Oats · Barley · Rye · Danish ·
Adults
Introduction
Celiac disease (CD) is characterized as a state of height-
ened immunological responsiveness to ingested gluten
(from wheat, barley or rye) in genetically susceptible indi-
viduals [1]. At the same time, CD is a multi-organ disease
with a wide variety of gastrointestinal and extra-intestinal
manifestations varying in nature and severity, which may
become symptomatic at all ages [2]. Untreated CD is asso-
ciated with a number of complications, e.g., chronic diar-
rhea, abdominal pain, anemia and growth problems in
Abstract
Purpose Celiac disease, an immunological response trig-
gered by gluten, affects ~1 % of the Western population.
Information concerning gluten intake in the general popula-
tion is scarce. We determined intake of gluten from wheat,
barley, rye and oat in the Danish National Survey of Diet
and Physical Activity 2005–2008. The study population
comprised a random cross-sectional sample of 1494 adults
20–75 years, selected from the Danish Civil Registration
System.
Methods Protein content in wheat, rye, barley and oat
was determined from the National Danish Food Composi-
tion Table and multiplied with the amount of cereal used
in recipes. Amount of gluten was calculated as amount of
cereal protein ×0.80 for wheat and oat, ×0.65 for rye and
* Tue Christensen
tuchr@food.dtu.dk
1 Division of Nutrition, National Food Institute, Technical
University of Denmark, Mørkhøj Bygade 19, 2860 Søborg,
Denmark
2 Faculty of Health and Medical Sciences, Center for Basic
Metabolic Research, University of Copenhagen,
Copenhagen, Denmark
3 Department of Nutrition, Exercise and Sports, Faculty
of Science, University of Copenhagen, Copenhagen,
Denmark
4 Food and Nutrition Science, Department of Biology
and Biological Engineering, Chalmers University
of Technology, Gothenburg, Sweden
5 Hans Christian Andersen Children’s Hospital, Odense
University Hospital/University of Southern Denmark,
Odense, Denmark
Eur J Nutr
1 3
infancy and childhood as well as osteoporosis and cancer
later in life [3, 4]. Historically, CD has been considered to
be uncommon, but recent studies in a number of popula-
tions have shown that CD affects around 1 % of the general
population [59]. The prevalence appears to be increasing
[1014], which may partly be caused by increased aware-
ness and improved diagnostic procedures. Additionally,
there seems to be a relationship between type 1 diabetes
and gluten intake [15], and type 1 diabetes and CD may be
overlapping [16]. In addition to CD, a condition referred to
as non-celiac gluten sensitivity (NCGS) has been described
[17]. These patients also benefit from a strictly gluten-free
diet, although allergic and autoimmune reactions have been
ruled out.
Gluten is found in wheat, rye and barley and refers to
a range of complex protein structures, and mainly two
types exist: the ethanol-soluble prolamins and the etha-
nol-insoluble glutenins [18]. The prolamines in wheat are
named gliadins, and the related proteins in rye and barley
are named secalins and hordeins, respectively. These have
been reported to exert similar detrimental responses in
CD patients [19]. Oats also contain gluten prolamins and
avenins, and it is still debated to which extent this should
be grouped with the other prolamins, as oats appear to be
harmless to most CD patients [20, 21]. However, a small
subset of celiac patients may be intolerant to the avenin
proteins, which make up only about 10 % of the total
proteins of oats [22]. Therefore, we included oat-derived
gluten in the analyses to make it possible to differentiate
between the gluten intake from wheat, barley, rye and oats.
Information concerning gluten intake in the general
population is scarce [23], and more information is needed
on population intake for setting up clinical trials, for exam-
ple, to determine how much gluten should be consumed
to reflect conditions for the general population. It is also
important to look at different population subgroups as
these might be targeted individually in future trials. Fur-
ther, information on population intake makes it possible
to determine whether gluten intake in various diseases and
conditions is any different from that of the general popu-
lation. We therefore determined the intake of gluten from
wheat, barley, rye and oats cross-sectionally in the Danish
National Survey of Diet and Physical Activity (DANSDA).
These data can be used to compare gluten intake in future
trials to that of an average population but also in targeted
population groups.
Subjects and methods
The study was conducted according to the guidelines laid
down in the Declaration of Helsinki II and was approved by
the Danish Data Protection Agency (j.no. 2008-54-0430).
According to the Danish National Committee on Health
Research Ethics, studies with no intervention and with no
invasive procedures, like the present study, in which only
dietary intake was recorded, do not require approval from
the committee. Verbal informed consent was obtained from
all subjects prior to the study.
Population
This study was based on data from the DANSDA 2005–
2008, which is a nation-wide and representative cross-sec-
tional survey among 4- to 75-year-old children and adults.
The study population comprised a simple random sam-
ple of 20- to 75-year-old adults selected from the Central
Office of Civil Registration [24]. Individuals who did not
speak Danish, boarding school students, disabled individu-
als and nursing home residents were excluded. Participants
received an invitation letter containing the participant infor-
mation and were then contacted by a trained, experienced
interviewer by telephone, and an appointment was made at
the participant’s home for a personal interview about back-
ground information, and instruction in filling in the food
record was made.
Overall participation rate was 53.3, 50.3 % for men and
56.3 % for women [25]. Examination of under-/over-report-
ers [26, 27] showed that 73 % of the participants were clas-
sified as acceptable reporters, 26 % as under-reporters and
1 % as over-reporters.
Anthropometric variables
Self-reported information about height and weight was
obtained through the personal face-to-face interview with
the participants. Body mass index (BMI) was calculated
from weight and height of the participants by dividing
body weight in kilograms by height in meters squared
(kg/m2).
Dietary intake
Dietary intake was recorded every day for seven consecu-
tive days in food records with pre-coded response catego-
ries, which included open-answer options. The amount
of foods eaten was given in predefined household meas-
ures (cups, spoons, slices, etc.) or estimated from photos
of various portion sizes. For food items not included in
the pre-coded food record, the participants wrote the type
of food and portion size eaten in open-answer categories.
Participants also received a food record booklet to take to
the workplace or to other places outside of the home on the
days of food recording. Details about the method and cal-
culation of intake of food and nutrients have been described
elsewhere [28].
Eur J Nutr
1 3
Table 1 Characteristics of the
study population (n = 1494)
(mean values and standard
deviations; percentages)
20–34 years
(n = 344)
35–44 years
(n = 341)
45–54 years
(n = 284)
55–64 years
(n = 306)
65–75 years
(n = 219)
Mean SD Mean SD Mean SD Mean SD Mean SD
Age (years)
M 27.9 4.37 39.3 3.0 49.8 2.9 59.6 2.8 69.2 2.9
F 27.8 4.18 39.8 2.8 49.8 2.9 59.5 2.7 69.4 3.1
P*0.967 0.135 0.854 0.647 0.657
Educationa
Basic school (%)
M 19 17 15 16 20
F 12 6 6 19 43
Vocational education (%)
M 44 44 46 48 49
F 37 37 41 43 33
Short higher education (%)
M 13 13 6 5 8
F 9 9 11 8 6
Long higher education (%)
M 24 26 33 31 23
F 42 48 32 30 18
P** 0.035 <0.0001 0.432 0.471 0.004
Urbanization
Capital city area (%)
M 19 18 13 14 12
F 27 19 11 14 13
Towns 100.000 inhab. (%)
M 15 9 8 5 6
F 14 9 12 8 10
Towns 10.000–99.999 inhab. (%)
M 27 25 23 28 28
F 24 25 28 26 27
Towns 500–9.999 inhab. (%)
M 17 29 29 29 36
F 22 26 28 29 34
Towns <500 inhab. (%)
M 22 19 27 24 18
F 13 21 21 23 16
P** 0.096 0.983 0.423 0.954 0.822
BMI (kg/m2)
M 24.9 3.6 25.9 3.7 25.9 4.2 26.8 3.8 26.3 3.5
F 24.0 4.5 24.4 4.7 24.9 4.8 25.0 4.0 25.4 4.3
P*0.049 0.002 0.068 <0.0001 0.092
Weight status
Overweight (%)
M 31 39 41 47 50
F 22 20 26 32 34
Eur J Nutr
1 3
Cereals were recorded in numerous foods in the pre-
coded dietary record. Participants were able to record two
types of rye bread, wheat bread (plain), wholemeal wheat
bread, hard bread, crackers, croissant, Danish pastry, cakes,
pancakes, pita bread, different types of bread containing
fast foods as burgers, pizzas, sausage rolls and hot dogs,
as well as four types of breakfast cereals, oatmeal and
other hot cereals in addition to open-answer possibilities.
The recipes in the dietary survey are based on commonly
used recipes in major Danish cookbooks as well as updated
information on market shares of purchased food products
in the Danish retail sector.
Gluten content in food items
All food products containing wheat, oat, barley and rye
were considered as containing gluten. From all food prod-
ucts reported in the food record, the gluten content of these
cereals was calculated as previously described [29]. Briefly,
since there is no information in food composition tables on
the gluten content of food products, the estimated amount
of protein from gluten-containing cereals according to the
Danish Food Composition Databank [30] was multiplied by
0.8 for wheat and oat [23, 31], by 0.65 for rye [32] and by
0.50 for barley [33]. The amount of gluten-containing cere-
als in composite foods was estimated from recipe informa-
tion from producers or the recipes used in the dietary survey.
Intakes of energy, nutrients and food items were calcu-
lated for each individual using the software system GIES
(version 1.000d; developed at National Food Institute,
Technical University of Denmark) and the Danish Food
Composition Databank [30].
Statistical analyses
All data were analyzed with the Statistical Package for the
Social Sciences software (version 21; IBM SPSS Statistics,
Inc., Chicago, USA), and a significance level of P < 0.05
was used (2-tailed tests). Results are shown as mean ± SD.
Analysis of variance (ANOVA) was applied to test for dif-
ferences in gluten intakes [absolute intake (mg/day), intake
per energy intake (mg/kJ) and intake per body weight (mg/
kg)] between gender (male; female), except for weight sta-
tus, educational level and urbanization which was deter-
mined with a χ2 test, and for differences in gluten intakes
[absolute intake (mg/day), intake per energy intake (mg/kJ)
and intake per body weight (mg/kg)] between age groups
(20–34, 35–44, 45–54, 55–64, 65–75 years). Post hoc com-
parisons across age groups were made using Bonferroni’s
post hoc test.
Results
Participant characteristics
As previously described [25], the distribution of gender and
age of the participants could be characterized as representa-
tive for the Danish population, aged 20–75 years in com-
parison with census data from Statistics Denmark. Data
from a total of 1494 adults were available and included in
the present study.
Characteristics of the study population are given in
Table 1. Women had higher educational levels than men,
reaching statistical significance in the 20- to 34-year-olds
(P = 0.035), in the 35- to 44-year-olds (P < 0.0001) and
in the 65- to 75-year-olds (P = 0.004). There were no
gender differences regarding urbanization in any of the
age groups. Men had higher BMI than women in all age
groups, but this only reached statistical significance in the
20- to 34-year-olds (P = 0.049), in the 35- to 44-year-olds
(P = 0.002) and in the 55- to 64-year-olds (P < 0.0001).
Also, there were more overweight men than women in 35-
to 64-year-olds (P 0.021).
20–34 years
(n = 344)
35–44 years
(n = 341)
45–54 years
(n = 284)
55–64 years
(n = 306)
65–75 years
(n = 219)
Mean SD Mean SD Mean SD Mean SD Mean SD
Obese (%)
M 8 13 13 19 10
F 9 14 12 11 16
P** 0.192 <0.0001 0.021 <0.0001 0.051
Table 1 continued
M males, F females, BMI body mass index
* ANOVA test for difference between men and women within the same age group
** χ2 test for difference between men and women within the same age group
a Basic school; 10 years or less of total education, vocational education; upper secondary school,
10–12 years, short higher education; 13–15 years, primarily theoretical, long higher education; 15+ years,
primarily theoretical
Eur J Nutr
1 3
Table 2 Percentiles of gluten
intake in (a) Danish men
(n = 677), 20–75 years, (b)
Danish women (n = 817),
20–75 years
Age (years) nPercentiles
10 20 30 40 50 60 70 80 90
(a)
Total gluten intake (mg/day)
20–34 132 7148 9035 11,039 12,305 13,556 14,281 15,247 17,720 20,111
35–44 146 7444 9316 10,043 11,053 11,206 13,435 15,105 16,498 19,179
45–54 132 5797 7328 8894 10,237 11,236 12,866 14,783 16,491 18,264
55–64 148 5349 7285 8709 9759 10,658 11,953 12,932 14,076 15,181
65–75 119 5566 6708 8038 8958 10,245 11,382 12,309 14,138 16,414
Total gluten intake, except from oats (mg/day)
20–34 132 6525 7906 9451 10,631 11,417 12,223 13,357 14,113 16,678
35–44 146 6307 7888 8675 9512 10,530 11,824 12,821 14,680 16,133
45–54 132 5119 6631 7810 8884 9864 10,711 12,175 13,867 15,794
55–64 148 4473 6277 7149 8177 8796 9543 10,455 11,817 13,133
65–75 119 5070 6154 6883 7563 8205 9106 10,194 10,975 13,001
Gluten intake from wheat (mg/day)
20–34 132 4882 6160 6991 7864 8927 9990 10,643 12,467 14,817
35–44 146 4212 5226 6211 7276 8102 8946 9957 11,117 13,182
45–54 132 2835 4022 5307 5816 6598 7546 8382 9432 11,628
55–64 148 2222 3218 3925 4790 5687 6441 7353 8153 9393
65–75 119 2300 3335 3977 4519 5231 5812 6685 7705 8643
Gluten intake from oats (mg/day)
20–34 132 310 489 579 773 1009 1206 1633 3368 5950
35–44 146 377 493 627 755 931 1232 1686 2653 5048
45–54 132 278 427 563 745 913 1180 1834 2862 4479
55–64 148 203 367 605 728 968 1352 2130 3299 4950
65–75 119 155 314 502 690 974 1199 2087 3625 5649
Gluten intake from barley (mg/day)
20–34 132 0.63 1.24 2.35 4.19 5.96 10.3 12.3 17 25.7
35–44 146 0.7 1.56 2.93 5.24 6.39 9.02 11.9 18.4 36.3
45–54 132 0.68 1.2 2.94 5.14 6.68 11.8 17.8 24 31.1
55–64 148 0.68 1.15 1.53 2.92 4.94 8.12 10.8 19.5 30.6
65–75 119 0.7 0.99 1.2 1.64 3.57 6.2 9.94 15.5 21.6
Gluten intake from rye (mg/day)
20–34 132 483 894 1283 1647 42,004 2522 2916 3453 3965
35–44 146 745 1101 1417 1844 2224 2843 3254 4051 5251
45–54 132 1009 1500 1877 2223 2917 3239 3887 4666 6218
55–64 148 1048 1499 2008 2620 3033 3482 3842 4398 5534
65–75 119 1375 1972 2289 2583 2853 3273 3757 4284 5456
(b)
Total gluten intake (mg/day)
20–34 212 5253 6640 7715 8958 9632 10,507 11,573 12,391 14,367
35–44 195 5921 7213 8135 8864 9565 10,397 11,354 12,449 14,560
45–54 152 4418 5779 6534 7817 8366 9051 9887 10,990 13,029
55–64 158 4164 5456 6057 6800 7338 8014 8912 9736 11,474
65–75 100 4895 5672 6508 7102 7672 8269 8995 10,664 11,675
Total gluten intake, except from oats (mg/day)
20–34 212 4598 5710 6678 7416 8191 8941 9744 10,787 12,609
35–44 195 4905 6069 6860 7589 8132 8711 9837 10,827 12,430
45–54 152 3900 4776 5563 6374 7216 7919 8817 9533 10,774
Eur J Nutr
1 3
Diet and gluten intake
Mean total gluten intake in the entire study population was
10,371 ± 4405 and 8777 ± 3631 mg/day with and without
gluten derived from oats, respectively. The 10th and 90th
percentiles were 5373 and 16156 mg/day, respectively,
including gluten from oats, and 4530 and 13591 mg/day,
respectively, excluding gluten from oats. Gluten derived
from wheat constituted 62 % of the gluten intake, including
gluten from oats, and 72 % excluding gluten from oats.
In Table 2, percentiles of gluten intakes in men and
women are listed separately. Mean total gluten intake was
12037 ± 4593 mg/day in men and 8991 ± 3385 mg/day in
women. Men had higher intakes of gluten than women in
all age groups (P < 0.0001) (Fig. 1), which corresponds to
their higher energy intake (data not shown). The intake of
different gluten types also tended to be higher in men than
in women with the exception of gluten from barley (Fig. 1).
Total gluten intake decreased with increasing age
(P < 0.0001), as did gluten intake from wheat (P < 0.0001).
Gluten intake from oats remained unchanging throughout
the age groups (P = 0.476), and the intake of gluten from
rye (P < 0.0001) and barley (P = 0.001) increased with
increasing age, independent of energy intake (Table 3) and
body weight (data not shown).
Bread contributed most to total gluten intake in all age
groups (Table 4), followed by breakfast cereals and pasta.
Regarding wheat, bread and pasta contributed the most,
whereas regarding oats, breakfast cereals contributed the
most.
Discussion
In the present study, we found that mean total gluten intake
was 10.4 ± 4.4 g/day, where 62 % derived from wheat and
8.8 ± 3.6 g/day not including oat. Also, we found that men
consumed more gluten than women, however not when
adjusting for energy intake, and that gluten consumption
decreased with age independent of energy intake and body
weight, suggesting that the diet of elderly individuals con-
tains less gluten than that of the younger population.
Table 2 continued Age (years) nPercentiles
10 20 30 40 50 60 70 80 90
55–64 158 3629 4611 5422 5976 6590 7273 7758 8727 10,174
65–75 100 3744 4587 5317 6109 6700 7073 7826 8467 10,086
Gluten intake from wheat (mg/day)
20–34 212 3497 4353 5268 5812 6602 7266 7770 9080 10,343
35–44 195 3490 4352 5038 5593 6164 6960 7588 8456 9781
45–54 152 2458 3228 3845 4532 4979 5632 6161 7181 7903
55–64 158 2061 2854 3531 4094 4383 4857 5518 5966 7444
65–75 100 1985 2615 3134 3731 4206 4737 5364 6402 7233
Gluten intake from oats (mg/day)
20–34 212 275 425 549 737 919 1187 1750 2245 3454
35–44 195 282 421 570 756 922 1238 1677 2352 3209
45–54 152 207 342 456 593 792 960 1455 2034 2980
55–64 158 132 251 321 427 547 650 861 1251 2332
65–75 100 222 335 432 556 665 893 1280 2000 3143
Gluten intake from barley (mg/day)
20–34 212 0.85 2.36 3.73 5.67 7.66 11.3 15.4 20.5 29.6
35–44 195 1.01 3.33 6.05 8.57 11.4 13.8 17.6 23.3 34
45–54 152 0.57 1.19 3.57 6.48 9.12 11.8 15.8 19.6 29.8
55–64 158 0.54 0.99 3.19 4.09 6.93 9.84 13.3 20.2 32.2
65–75 100 0.61 0.89 1.33 2.55 4.29 8.34 12.5 17.9 23.5
Gluten intake from rye (mg/day)
20–34 212 394 727 984 1159 1433 1631 1940 2346 3124
35–44 195 695 973 1299 1541 1786 2009 2429 2804 3789
45–54 152 809 1065 1352 1698 1918 2215 2466 2811 3584
55–64 158 662 1004 1389 1668 1962 2246 2741 3097 3523
65–75 100 1096 1439 1663 1863 2181 2395 2838 3169 3506
Eur J Nutr
1 3
These data are less than the previously reported mean
gluten intake of 13.1 g/day among Dutch adults [23]. Gen-
erally, the Danish dietary patterns are similar to those seen
among the Dutch, but this difference in gluten intake may
be caused by a combination of differences in intake of vari-
ous types of cereals and the different methods applied to
estimate gluten intake from different sources, as the esti-
mated amount of protein from gluten-containing cereals
was multiplied by 0.8 for wheat and oat [23, 31], by 0.65
for rye [32] and by 0.50 for barley [33] in the present study
and by 0.8 for all grain types in the Dutch study [23]. Here,
information on the different sources of gluten was not
Fig. 1 Daily intake of gluten
(mg/day, 95 % CI) from oats,
wheat, rye and barley, and total
gluten in 1494 20- to 75-year-
old Danish men and women. a
20- to 34-year-olds (n = 344).
Differences between men
(dark bars) and women (light
bars) (oats, P = 0.012; wheat,
P < 0.0001; rye, P 0.0001;
barley, P = 0.074; total,
P < 0.0001). b 35- to 44-year-
olds (n = 341). Differences
between men (dark bars) and
women (light bars) (oats,
P = 0.089; wheat, P < 0.0001;
rye, P < 0.0001; barley,
P = 0.116; total, P < 0.0001). c
45- to 54-year-olds (n = 284).
Differences between men
(dark bars) and women (light
bars) (oats, P = 0.008; wheat,
P < 0.0001; rye, P < 0.0001;
barley, P = 0.979; total,
P < 0.0001). d 55- to 64-year-
olds (n = 306). Differences
between men (dark bars) and
women (light bars) (oats,
P < 0.0001; wheat, P < 0.0001;
rye, P < 0.0001; barley,
P = 0.878; total, P < 0.0001). e
65- to 75-year-olds (n = 219).
Differences between men
(dark bars) and women (light
bars) (oats, P = 0.008; wheat,
P = 0.004; rye, P < 0.0001;
barley, P = 0.744; total,
P < 0.0001). f 20- to 75-year-
olds (n = 1494). Differences
between men (dark bars) and
women (light bars) (oats,
P < 0.001; wheat, P < 0.001;
rye, P < 0.0001; barley,
P = 0.037; total, P < 0.0001)
Eur J Nutr
1 3
provided, but likely rye and barley contributed little to the
total gluten intake as these are not commonly consumed
cereals in the Netherlands.
Remarkably, intake of gluten from wheat decreased with
increasing age, whereas gluten intake from rye increased
with increasing age. This observation corresponds with
the fact that the intake of products with wheat, such as fast
food, was higher in the younger part of the population,
whereas the elderly individuals still seem to prefer cereal
products with rye, as suggested by the fact that rye glu-
ten from bread was increasing with increasing age, which
probably is due to the frequent use of rye bread in the Dan-
ish diet, in particular as part of a traditional lunch meal
[25]. Gluten from oats was derived mainly from breakfast
cereals, and rolled oats are a major ingredient in a typical
Danish breakfast meal [25]. In general, the consumption of
barley in Danish adults was very low and with quite a large
variation.
There were some strengths and limitations in the present
study. We have not been able to find any food databases
with detailed information on gluten content from wheat,
barley, rye and oats, and our calculations are approxi-
mate. As all studies relying on self-reporting, this study
may be affected by self-report bias. Both under-reporting
of energy as well as over-estimation of socially acceptable
foods might occur. However, the most common foods to
over-report are meat, fish, vegetables, salad and fruit, while
foods such as cakes, cookies, sugar, candies and fats might
be under-reported [34]. In that matter, bread is considered
a “neutral” food. Validation of the current dietary survey
indicated an underestimation of energy intake of approxi-
mately 12 % at group level [28].
The strengths of the study include the access to detailed
dietary data for 7 days that enabled analysis of the gluten
intake from different sources. Dietary data were collected
all year round to compensate for seasonal variation in food
intake. Furthermore, the pre-coded food diary covers both
week days and weekend days. The 7-day estimated food
record/diary is a prospective method, which is not affected
by the memory since the foods and beverages are recorded
close to the time of consumption. Another advantage of
the methods is that portion sizes can be more accurately
estimated compared to retrospective methods. The dietary
survey estimates the consumed amounts on the basis of
household measures, standard portions and photo series,
which can reduce the respondent burden compared to,
e.g., weighed dietary record. A less respondent burden can
ensure a more accurate estimation of the consumed foods.
In a comparison of dietary assessment methods, the 7-day
food record/dairy was found to give the best estimates of
dietary intake compared with FFQ and 24-h recall [35].
Validation of the current estimated food dairy against
weighed records has shown the ability to cross-classify in
good accordance with results of other validation studies,
thus making the pre-coded food diary an appropriate tool
for the classification of individuals according to high or low
intakes of nutrients [36].
Furthermore, the study was based on a random sample
of the Danish adult population including individuals with
a wide age range from both urban and rural areas, thus
likely to resemble the general population. In an earlier
study of the demographic composition of the DANSDA
participants, it was concluded that the study sample was
representative for the Danish adult population with respect
Table 3 Daily gluten intake in 20- to 75-year-old Danish adults (n = 1494) (mean values and standard deviation)
a, b, c, d values within a row with different superscript letters were significantly different for each gluten intake (ANOVA test with Bonferroni
post hoc test), P < 0.05
20–34 years
(n = 344)
35–44 years
(n = 341)
45–54 years
(n = 284)
55–64 years
(n = 306)
65–75 years
(n = 219)
Mean SD Mean SD Mean SD Mean SD Mean SD
Gluten (mg/day) 11209a4390 11252a4471 10207b4604 9239b3981 9478b4090
Total, except oats 9558a3744 9575a3667 8636b3672 7841b3227 7798b3318
Wheat 7722a3422 7283a3062 6007b2879 5229c2558 5053c2851
Oats 1651a1843 1677a1983 1571a2026 1398a1835 1680a2145
Barley 12a,b 13 14a13 13a,b 14 11a,b 14 9b12
Rye 1825a,b 1222 2278b,c 1580 2616c,d 1793 2601c,d 1636 2736d1401
Gluten per energy intake (mg/kJ) 1.20a0.34 1.20a0.32 1.13b0.31 1.07b0.35 1.09b0.31
Total, except oats 1.02a0.28 1.02a0.27 0.96b0.25 0.91b0.28 0.90b0.26
Wheat 0.82a,b 0.28 0.78b0.26 0.67c0.24 0.61d0.25 0.58d0.24
Oats 0.18a0.2 0.18a0.19 0.17a0.18 0.16a0.2 0.19a0.24
Barley 0.01a,b 0.01 0.02a0.02 0.01a,b 0.02 0.01a,b 0.02 0.01b0.02
Rye 0.20a,b 0.12 0.24b0.13 0.29c0.16 0.30c0.16 0.32c0.15
Eur J Nutr
1 3
to gender, age, urbanization, and education; however, the
younger men were slightly underrepresented, which, how-
ever, was considered not to influence the generalizability of
the results [25]. The influence of non-response bias cannot,
however, be excluded. Because of the high demand of the
study on participants, it is possible that responders consti-
tute a selected group of more motivated participants for a
healthy lifestyle than non-responders [37].
Recently, two large clinical trials [38, 39] have shown
no effect of the introduction of gluten in the infant diet
early or late or introduction of a small amount of gluten
concurrently with breastfeeding on the subsequent develop-
ment of celiac disease. Also there is no evidence that the
amount of gluten in the diet influences the risk of celiac
disease [40]. The scarce information about the level of glu-
ten intake in the general population and in population sub-
groups makes it difficult to set an appropriate level of glu-
ten intake in intervention trials. Further, comparing gluten
intake between disease states and a comparable population
requires a reliable determination of a normal gluten intake.
The data provided in this paper provide a framework for
further studies on the putative associations between quanti-
tative and qualitative gluten consumption and the manifes-
tations of CD as well as of the less well-established entity
NCGS and of other diseases such as type 1 diabetes melli-
tus that might be linked to gluten intake [15, 41]. A method
Table 4 Contribution of wheat,
oats, barley and rye and total
gluten intake from major food
groups in 20- to 75-year-old
Danish adults (n = 1494)
a Bread, bun, hard bread, biscuit, pretzel
b Corn flakes, rolled oat, muesli, porridge, Danish crumble
c Burger, taco, tortilla, pita, croissant, pizza, hot dog, French toast
d Pasta, cooked cereals
e Meatballs, vegetable balls, fish balls, liver paste, pâté, shellfish in pastry, cheese dippers, licorice
20–34 years
(n = 344)
35–44 years
(n = 341)
45–54 years
(n = 284)
55–64 years
(n = 306)
65–75 years
(n = 219)
Total gluten (mg/day)
Breada6461 7499 7375 7054 7240
Breakfast cerealsb1643 1716 1926 1800 2054
Fast foodc2627 1770 1247 1042 781
Pastad1027 847 646 414 478
Othere534 588 524 497 483
Wheat (mg/day)
Breada4196 4726 4301 4039 4080
Breakfast cerealsb39 41 45 85 114
Fast foodc2534 1708 1204 1008 753
Pastad1027 847 646 414 478
Othere505 549 499 466 454
Oats (mg/day)
Breada470 507 455 421 421
Breakfast cerealsb1108 1105 1081 939 1227
Fast foodc46 28 15 9.3 5.3
Pastad00000
Othere27 37 21 29 27
Barley (mg/day)
Breada9.1 12 11 10 8.1
Breakfast cerealsb0.9 0.9 0.6 0.5 0.5
Fast foodc1.6 1.2 0.6 0.4 0.5
Pastad00000
Othere00000
Rye (mg/day)
Breada1787 2254 2596 2584 2716
Breakfast cerealsb4.9 4.6 4.6 8.4 13
Fast foodc31 18 11 6.3 3.9
Pastad00000
Othere1.8 1.4 3.9 2.6 3.0
Eur J Nutr
1 3
could be to associate gluten consumption on an individual
basis with the subsequent development of CD, feasible in
large population-based surveys.
Conclusion
This study provides nationally representative population-
based data on gluten intake from different sources in 20- to
75-year-old Danish adults, with a mean total gluten intake
of 10.4 g/day, 12.0 g/day in men and 9.0 g/day in women.
The majority of ingested gluten was derived from wheat.
Total gluten intake decreased with increasing age as did
gluten intake from wheat, whereas intake of gluten from
rye and barley increased with increasing age, also when
adjusted for energy intake and body weight.
Acknowledgments The authors wish to thank Data Warehouse
Manager Karsten Kørup and Data Scanning Manager Hanne-Jette
Hinsch as well as Majken Ege and Karin Hess Ygil (Division of
Nutrition, National Food Institute, Technical University of Denmark)
for contributing to the data processing. The authors express their
gratitude to all the participating children and parents in DANSDA.
The authors conceived the study (C.H., S.H.), designed the analyses
of this study (C.H.) and were responsible for the design and collec-
tion of data from the Danish National Survey of Diet and Physical
Activity (S.F., J.M., E.T.) and responsible for data interpretation and
processing (T.C.). C.H. was responsible for analyses of data and writ-
ing the manuscript. All authors participated in the discussion of the
results and revision of the manuscript. This study was supported by
the Danish Strategic Research Council (Project No. 09-06-5149), and
the Danish National Survey of Diet and Physical Activity (DANSDA)
was financed by the Ministry of Food, Agriculture and Fisheries.
Compliance with ethical standards
Conflict of interest None of the authors have declared any conflict
of interest.
References
1. Sollid LM, Jabri B (2013) Triggers and drivers of autoimmunity:
lessons from coeliac disease. Nat Rev Immunol 13:294–302
2. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guanda-
lini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman
EG (2005) Guideline for the diagnosis and treatment of celiac
disease in children: recommendations of the North American
Society for Pediatric Gastroenterology, Hepatology and Nutri-
tion. J Pediatr Gastroenterol Nutr 40:1–19
3. American Gastroenterological Association (2001) American
Gastroenterological Association medical position statement:
celiac sprue. Gastroenterology 120:1522–1525
4. Mäki M, Collin P (1997) Coeliac disease. Lancet 349:1755–1759
5. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH
(1997) Prevalence of coeliac disease in Northern Ireland. Lancet
350:1370
6. Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV,
Hadjivassiliou M, Lobo AJ (2003) A primary care cross-sec-
tional study of undiagnosed adult coeliac disease. Eur J Gastro-
enterol Hepatol 15:407–413
7. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R,
Reader R, Holmes GK, Khaw KT (2003) Seroprevalence, cor-
relates, and characteristics of undetected coeliac disease in Eng-
land. Gut 52:960–965
8. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S,
Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura
A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray
JA, Horvath K (2003) Prevalence of celiac disease in at-risk and
not-at-risk groups in the United States: a large multicenter study.
Arch Intern Med 163:286–292
9. Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C,
Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, Macneil J,
Mack D, Patel D, Moher D (2005) The prevalence of celiac dis-
ease in average-risk and at-risk Western European populations: a
systematic review. Gastroenterology 128:S57–S67
10. Ludvigsson JF, Rubio-Tapia A, van Dyke CT, Melton LJ III,
Zinsmeister AR, Lahr BD, Murray JA (2013) Increasing inci-
dence of celiac disease in a North American population. Am J
Gastroenterol 108:818–824
11. Dydensborg S, Toftedal P, Biaggi M, Lillevang ST, Hansen DG,
Husby S (2012) Increasing prevalence of coeliac disease in Den-
mark: a linkage study combining national registries. Acta Paedi-
atr 101:179–184
12. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp
SL, Gelfond D, Puppa E, Sferruzza A, Fasano A (2010) Natural
history of celiac disease autoimmunity in a USA cohort followed
since 1974. Ann Med 42:530–538
13. Rewers M (2005) Epidemiology of celiac disease: what are the
prevalence, incidence, and progression of celiac disease? Gastro-
enterology 128:S47–S51
14. Myleus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Hog-
berg L, Karlsson E, Lagerqvist C, Norstrom F, Rosen A, Sand-
strom O, Stenhammar L, Stenlund H, Wall S, Carlsson A (2009)
Celiac disease revealed in 3 % of Swedish 12-year-olds born
during an epidemic. J Pediatr Gastroenterol Nutr 49:170–176
15. Antvorskov JC, Josefsen K, Engkilde K, Funda DP, Buschard K
(2014) Dietary gluten and the development of type 1 diabetes.
Diabetologia 57:1770–1780
16. Cohn A, Sofia AM, Kupfer SS (2014) Type 1 diabetes and celiac
disease: clinical overlap and new insights into disease pathogen-
esis. Curr Diab Rep 14:517
17. Goldstein NS (2004) Non-gluten sensitivity-related small bowel
villous flattening with increased intraepithelial lymphocytes: not
all that flattens is celiac sprue. Am J Clin Pathol 121:546–550
18. Blomfeldt TO, Kuktaite R, Johansson E, Hedenqvist MS (2011)
Mechanical properties and network structure of wheat gluten
foams. Biomacromolecules 12:1707–1715
19. Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W,
Drijfhout JW, Van Veelen PA, Koning F (2003) Characteriza-
tion of cereal toxicity for celiac disease patients based on protein
homology in grains. Gastroenterology 125:1105–1113
20. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM,
Jarvinen RM, Uusitupa MI, Julkunen RJ (1995) A comparison of
diets with and without oats in adults with celiac disease. N Engl
J Med 333:1033–1037
21. Kemppainen T, Janatuinen E, Holm K, Kosma VM, Heikkinen
M, Maki M, Laurila K, Uusitupa M, Julkunen R (2007) No
observed local immunological response at cell level after five
years of oats in adult coeliac disease. Scand J Gastroenterol
42:54–59
22. Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Kon-
ing F, Jung G, Roepstorff P, Lundin KE, Sollid LM (2004) The
molecular basis for oat intolerance in patients with celiac dis-
ease. PLoS Med 1:e1
23. van Overbeek FM, Uil-Dieterman IG, Mol IW, Kohler-Brands
L, Heymans HS, Mulder CJ (1997) The daily gluten intake in
Eur J Nutr
1 3
relatives of patients with coeliac disease compared with that
of the general Dutch population. Eur J Gastroenterol Hepatol
9:1097–1099
24. Pedersen CB (2011) The Danish Civil Registration System.
Scand J Public Health 39:22–25
25. Pedersen AN, Fagt S, Groth MV, Christensen T, Biltoft-Jensen
A, Matthiessen J, Andersen NL, Kørup K, Hartkopp H, Ygil KH,
Hinsch H-J, Saxholt E, and Trolle E. Dietary habits in Denmark
2003–2008. Main results. 2010. National Food Institute, Techni-
cal University of Denmark
26. Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR,
Coward WA, Prentice AM (1991) Critical evaluation of energy
intake data using fundamental principles of energy physiology:
1. Derivation of cut-off limits to identify under-recording. Eur J
Clin Nutr 45:569–581
27. Black AE (2000) Critical evaluation of energy intake using the
Goldberg cut-off for energy intake: basal metabolic rate. A prac-
tical guide to its calculation, use and limitations. Int J Obes Relat
Metab Disord 24:1119–1130
28. Biltoft-Jensen A, Matthiessen J, Rasmussen LB, Fagt S, Groth
MV, Hels O (2009) Validation of the Danish 7-day pre-coded
food diary among adults: energy intake v. energy expenditure
and recording length. Br J Nutr 102:1838–1846
29. Hoppe C, Trolle E, Gondolf UH, Husby S (2013) Gluten intake
in 6-36-month-old Danish infants and children based on a
national survey. J Nutr Sci 2:1–7
30. Saxholt E, Christensen AT, Møller A, Hartkopp H, Ygil KH,
Hels OH (2008) Danish Food Composition Databank, revision 7.
Division of Nutrition, National Food Institute, Technical Univer-
sity of Denmark
31. Wieser H, Seilmeier W, Belitz HD (1980) Comparative investi-
gations of partial amino acid sequences of prolamines and glute-
lins from cereals. II. Fractionation of glutelins (author’s transl).
Z Lebensm Unters Forsch 171:430–436
32. Gellrich C, Schieberle P, Weiser H (2003) Biochemical charac-
terization and quantification of the storage protein (secalin) types
in rye flour. Cereal Chem 80:102–109
33. Ellis HJ, Freedman AR, Ciclitira PJ (1990) Detection and esti-
mation of the barley prolamin content of beer and malt to assess
their suitability for patients with celiac-disease. Clin Chim Acta
189:123–130
34. Livingstone MB, Black AE (2003) Markers of the validity of
reported energy intake. J Nutr 133(Suppl 3):895S–920S
35. Bingham SA, Gill C, Welch A, Cassidy A, Runswick SA, Oakes
S, Lubin R, Thurnham DI, Key TJ, Roe L, Khaw KT, Day NE
(1997) Validation of dietary assessment methods in the UK arm
of EPIC using weighed records, and 24-hour urinary nitrogen
and potassium and serum vitamin C and carotenoids as biomark-
ers. Int J Epidemiol 26(Suppl 1):S137–S151
36. Knudsen VK, Gille MB, Nielsen TH, Christensen T, Fagt S,
Biltoft-Jensen A (2011) Relative validity of the pre-coded food
diary used in the Danish National Survey of Diet and Physical
Activity. Public Health Nutr 14:2110–2116
37. Tolonen H, Laatikainen T, Helakorpi S, Talala K, Martelin T,
Prattala R (2010) Marital status, educational level and house-
hold income explain part of the excess mortality of survey non-
respondents. Eur J Epidemiol 25:69–76
38. Vriezinga SL, Auricchio R, Bravi E, Castillejo G, Chmielewska
A, Crespo EP, Kolacek S, Koletzko S, Korponay-Szabo IR,
Mummert E, Polanco I, Putter H, Ribes-Koninckx C, Shamir
R, Szajewska H, Werkstetter K, Greco L, Gyimesi J, Hartman
C, Hogen EC, Hopman E, Ivarsson A, Koltai T, Koning F, Mar-
tinez-Ojinaga E, te Marvelde C, Pavic A, Romanos J, Stoopman
E, Villanacci V, Wijmenga C, Troncone R, Mearin ML (2014)
Randomized feeding intervention in infants at high risk for celiac
disease. N Engl J Med 371:1304–1315
39. Lionetti E, Castellaneta S, Francavilla R, Pulvirenti A, Tonutti
E, Amarri S, Barbato M, Barbera C, Barera G, Bellantoni A,
Castellano E, Guariso G, Limongelli MG, Pellegrino S, Polloni
C, Ughi C, Zuin G, Fasano A, Catassi C (2014) Introduction of
gluten, HLA status, and the risk of celiac disease in children. N
Engl J Med 371:1295–1303
40. Szajewska H, Shamir R, Chmielewska A, Piescik-Lech M,
Auricchio R, Ivarsson A, Kolacek S, Koletzko S, Korponay-
Szabo I, Mearin ML, Ribes-Koninckx C, Troncone R (2015)
Systematic review with meta-analysis: early infant feeding
and coeliac disease—update 2015. Aliment Pharmacol Ther
41:1038–1054
41. Hogg-Kollars S, Al DD, Tait K, Rostami K (2014) Type 1 diabe-
tes mellitus and gluten induced disorders. Gastroenterol Hepatol
Bed Bench 7:189–197
... The gluten dose of 14 g/day was chosen in order to be similar to the gluten intake in the general population (10 g/day) and Swedish IBS patients (11 g/ day). 6,7 The participants were instructed to sprinkle the powder sachets over their meal boxes (twice per day) during the different diet periods. Although the plastic sachets were identical (except marked with 'A' or 'B'), the contents differed in colour. ...
... 19 During both interventions, the FODMAP content was stable and similar to the reported FODMAP intake in IBS. 20 The participants were challenged with moderate dosages of gluten (14 g/day), which was chosen in order to be similar to the actual gluten intake in the general population (10 g/day) and Swedish IBS patients (11 g/day), 6,7 and it was not expected to aggravate GI symptoms to an extent that would risk unblinding or reduce compliance. ...
... Although the use of serum alkylresorcinols as a biomarker for a gluten-free diet remains to be validated in larger studies, several studies have shown its potential. [7][8][9] The findings in our sample that serum alkylresorcinols were lower after the gluten-free intervention compared with the gluten-containing intervention support this, and indicates good compliance to the interventions, which we consider as a strength. Another strength of this study is the adequate blinding of the participants and investigators, and confounding factors were minimised by using the randomised crossover design, 23 Limitations of this study include the small sample size. ...
Article
Full-text available
Background A gluten‐free diet reduces symptoms in some patients with irritable bowel syndrome (IBS) through unclear mechanisms. Aims To assess the effects of gluten‐free versus gluten‐containing diet on symptoms and the gut microenvironment, and to identify predictors of response to the gluten‐free diet in IBS. Methods Twenty patients with IBS and 18 healthy controls (HC) followed a gluten‐free diet during two 14‐day intervention periods where they sprinkled either gluten (14 g/day) or rice flour powder over their meals. Primary outcomes included effects of the interventions on IBS symptoms (IBS‐SSS) and bowel habits. Secondary outcomes included effects of gluten‐free diet on faecal microbiota and metabolite profile. Results IBS symptoms improved during the gluten‐free (p = 0.02), but not the gluten‐containing period, with no difference between the interventions. IBS patients reported fewer loose stools during the gluten‐free intervention (p = 0.01). Patients with IBS and HC presented distinct metabolite profiles based on the effects of the gluten‐free diet (p < 0.001). True responders (reduced IBS‐SSS by ≥50 solely after gluten‐free period) and non‐responders were discriminated based on the effects of the gluten‐free diet on the microbiota (p < 0.01) and metabolite profiles (p < 0.001). The response to the gluten‐free diet could be predicted by the metabolite profile before the intervention (p < 0.001). Conclusions A gluten‐free diet may influence symptoms in a subset of patients with IBS, with a particular effect on bowel habits. A gluten‐free diet seems to impact the gut microenvironment. Responsiveness to the gluten‐free diet may be predicted by the metabolite profile. Clinicaltrials.gov: NCT03869359.
... The gluten dose of 14 g/day was chosen in order to be similar to the gluten intake in the general population (10 g/day) and Swedish IBS patients (11 g/ day). 6,7 The participants were instructed to sprinkle the powder sachets over their meal boxes (twice per day) during the different diet periods. Although the plastic sachets were identical (except marked with 'A' or 'B'), the contents differed in colour. ...
... 19 During both interventions, the FODMAP content was stable and similar to the reported FODMAP intake in IBS. 20 The participants were challenged with moderate dosages of gluten (14 g/day), which was chosen in order to be similar to the actual gluten intake in the general population (10 g/day) and Swedish IBS patients (11 g/day), 6,7 and it was not expected to aggravate GI symptoms to an extent that would risk unblinding or reduce compliance. ...
... Although the use of serum alkylresorcinols as a biomarker for a gluten-free diet remains to be validated in larger studies, several studies have shown its potential. [7][8][9] The findings in our sample that serum alkylresorcinols were lower after the gluten-free intervention compared with the gluten-containing intervention support this, and indicates good compliance to the interventions, which we consider as a strength. Another strength of this study is the adequate blinding of the participants and investigators, and confounding factors were minimised by using the randomised crossover design, 23 Limitations of this study include the small sample size. ...
... [11] The average gluten intake in the general population is around 10-20 grams of gluten daily. [12] The same amount has been shown to be sufficient to establish a dosedependent response to enteropathy in CeD patients after 4 to 8 weeks of gluten challenge. [13] Considering the relevance of the proteolysis-resistant 33-mer in CeD, its concentration in wheat flour was quantified as 90.9-602.6 ...
... We hypothesized that above the CAC, the 33-mer could form small oligomers, ranging from dimers to decamers, as found previously by 33-mer crosslinking experiments. [12] Previously, Kogan et al. showed similar behavior of proline and glutamine-rich domain from zein protein. [20] They showed that the surfactant activity gives the property to penetrate cells. ...
Article
Full-text available
Gluten related‐disorders have a prevalence of 1‐5% worldwide triggered by the ingestion of gluten proteins in wheat, rye, barley, and some oats. In wheat gluten, the most studied protein is gliadin, whose immunodominant 33‐mer amino acid fragment remains after digestive proteolysis and accumulates in the gut mucosa. Here, we report the formation of 33‐mer thin‐plate superstructures using intrinsic tyrosine (Tyr) steady‐state fluorescence anisotropy and cryo‐TEM in combination with water tension measurements. Furthermore, we showed that fluorescence decay measurements of 33‐mer intrinsic fluorophore Tyr provided information on the early stages of the formation of the thin‐plate structures. Finally, conformational analysis of Tyr residues using minimalist models by molecular dynamic simulations (MD) demonstrated that changes in Tyr rotamer states depend on the oligomerization stage. Our findings further advance the understanding of the formation of the 33‐mer gliadin peptide superstructures and their relation to health and disease.
... A lifelong gluten-free diet is the only accepted medical treatment for gluten-related disorders. Despite the importance and effectiveness of a glutenfree diet, adherence to it remains a difficult goal [3]. Commercially available gluten-free products are often less palatable and less available. ...
Article
Full-text available
Celiac disease is one of the most common metabolic disorders. Patients suffering from celiac disease have a limited intake of nutritionally and sensory valuable foods. On the other side, due to the absence of gluten in this kind of food there is found very often high representation of artificial food additives in order to replace gluten technological properties. The aim of this work was to design innovative gluten-free muesli bars, with no food additive use, sensory and nutritionally valuable, in terms of high protein and fiber content, no addition of sugar and labelled by approved nutrition claims. The muesli products were prepared from three types of gluten-free flakes, namely oats, rice and buckwheat and using of raw materials such as mixture of nuts, seeds, lyophilized fruit, mango puree and oligofructose, together, represented by 13 variants of samples (standard sample included). Prepared products were assessed by texturometric analysis and sensory evaluation (panel test). We analyzed the texture of all gluten-free bars by the TA.XT Plus texturometer (Stable Micro Systems, Surrey, Great Britain). Sensory analysis showed, that sample consisting of oatmeal, a mixture of nuts and oligofructose was the most acceptable by trained evaluators. The use of nuts in the preparation of muesli bars showed good textural and taste properties. The worst rated were bars prepared from rice flakes. The sample prepared from rice flakes, a mixture of nuts and oligofructose showed the highest firmness that is undesirable from consumer point of view. We can confirm the use of three nutritional claims on all designed gluten free products for protein content, high fiber and with no added sugars are by the appropriate EU regulatives. Due to the lack of quality products for celiacs on the market, we recommend designed additive free samples prepared from oatmeal and buckwheat flakes to producers in order to expand the range of quality products for people with gluten-free diet in the future.
... [5] Gluten consumption in a Western diet is estimated to be 5-20 g per day, and it has been linked to a variety of health problems. [6] Gluten-containing cereals (wheat, rye, barley, and oats) are essential staple foods. Gluten is one of the most complex protein networks and is crucial in controlling dough rheological qualities. ...
Article
Full-text available
Gluten is a herbal protein found in grains such as wheat, rye, and barley. Casein is an animal protein found in cows, goats, sheep, and human milk. Since it is not digested properly in people suffering from intestinal-based psychological disorders, its chemical properties turn into structures similar to morphine. Gluten and casein peptides such as gluteomorphin and casomorphine were found in urine samples taken from patients with diseases like Down syndrome, schizophrenia, depression, autism, and epilepsy. These peptides cross the vascular structure through the blood to the brain and the fluid in the brain, causing the function of some areas of the brain to be slowed down. This condition, which originates in the digestive system, is more frequent in people who have an intestine-based psychiatric disease. The psychiatric effects of gluten and casein on different individuals were examined in this review based on the research in the literature, and it was revealed that the findings of these effects were not the same in everyone. Although a gluten-free, casein-free diet is not a cure-all, it can help lessen psychological symptoms.
... 15,19 Thus, in the present trial we challenged with 10 g of gluten, which is the standard daily gluten intake in the Danish population. 35 Furthermore, some of the placebo vehicles, especially among studies that found no result, contained ...
Article
Full-text available
Background The popularity of the gluten‐free diet and sales of gluten‐free products have increased immensely. Aims To investigate whether gluten induces gastrointestinal symptoms, measured by self‐reported questionnaires, as well as mental health symptoms in adolescents from a population‐based cohort. Methods The eligible participants (n = 273) were recruited from a population‐based cohort of 1266 adolescents and had at least four different gastrointestinal symptoms. Phase one (n = 54) was a run‐in phase where the participants lived gluten‐free for 2 weeks. If they improved they continued to phase 2 (n = 33), a blinded randomised cross‐over trial. Participants were blindly randomised either to start with 7 days of gluten, eating two granola bars containing 10 g of gluten or to 7 days on placebo, eating two granola bars without gluten, followed by the reverse and separated by a 7‐day washout period. The effects of the intervention on gastrointestinal symptoms and mental health symptoms were assessed. Results In total, 54/273 participants entered the run‐in phase and 35 were eligible for randomization. A total of 33 were randomised and 32 completed the trial. The median age was 20.3 (IQR 19.2–20.9) and 32/33 participants were females. Compared with a placebo, gluten did not induce gastrointestinal symptoms. The difference in the average VAS was −0.01 (95% confidence interval −2.07 to 2.05). Nor did we find a difference in the outcomes measuring mental health. Conclusion Compared with placebo, adding gluten to the diet did not induce gastrointestinal symptoms or worsened mental health in adolescents recruited from a population‐based cohort. The trial registration number is NCT04639921.
... The gluten-containing suspension included an estimated 3 g of gluten protein, 100 cc still water, and 7 g Tang (see Table 1, Supplementary Digital Content 1, http://links.lww.com/AJG/C312). The Osborne equation was used to calculate the amount of gluten The American Journal of GASTROENTEROLOGY in a 40-gram serving (13,14). Bread was baked using 1,000 g whole wheat flour, 15 g salt, 60 g sugar, 53 g yeast, and supplemented with 10 g Bob's Red Mill vital gluten to achieve 3 g of gluten, equivalent to approximately 1 slice of commercial bread. ...
Article
Introduction: Treated patients with celiac disease (CeD) and nonceliac gluten sensitivity (NCGS) report acute, transient, incompletely understood symptoms after suspected gluten exposure. To determine whether (i) blinded gluten exposure induces symptoms, (ii) subjects accurately identify gluten exposure, and (iii) serum interleukin-2 (IL-2) levels distinguish CeD from NCGS subjects after gluten exposure. Methods: Sixty subjects (n = 20 treated, healed CeD; n = 20 treated NCGS; n = 20 controls) were block randomized to a single, double-blind sham (rice flour) or 3-g gluten challenge with 72-hours follow-up. Twelve serial questionnaires (100 mm visual analog scale; pain, bloating, nausea, and fatigue) and 10 serial plasma samples were collected. Mucosal permeability was assessed using both urinary lactulose-13C mannitol ratios and endoscopic mucosal impedance. Results: Thirty-five of 40 (83%) subjects with CeD and NCGS reported symptoms with gluten (8 CeD, 9 NCGS) and sham (9 CeD, 9 NCGS) compared with 9 of 20 (45%) controls after gluten (n = 6) and sham (n = 3). There was no significant difference in symptoms among groups. Only 2 of 10 subjects with CeD and 4 of 10 NCGS identified gluten, whereas 8 of 10 subjects with CeD and 5 of 10 NCGS identified sham. A significant plasma IL-2 increase occurred only in subjects with CeD after gluten, peaking at 3 hours and normalizing within 24 hours postchallenge despite no significant intestinal permeability change from baseline. Discussion: Symptoms do not reliably indicate gluten exposure in either subjects with CeD or NCGS. IL-2 production indicates a rapid-onset gluten-induced T-cell activation in CeD despite long-standing treatment. The effector site is unknown, given no increased intestinal permeability after gluten.
Article
Full-text available
LINKED CONTENT This article is linked to Algera et al papers. To view these articles, visit https://doi.org/10.1111/apt.17239 and https://doi.org/10.1111/apt.17253
Article
Full-text available
Coeliac disease is a lifelong immune‐mediated enteropathy with systemic features associated with increased morbidity and modestly increased mortality. Treatment with a strict gluten‐free diet improves symptoms and mucosal damage but is not curative and low‐level gluten intake is common despite strict attempts at adherence. Regular follow‐up after diagnosis is considered best‐practice however this is executed poorly in the community with the problem compounded by the paucity of data informing optimal approaches. The aim of dietary treatment is to resolve symptoms, reduce complication risk and improve quality of life. It follows that the goals of monitoring are to assess dietary adherence, monitor disease activity, assess symptoms and screen for complications. Mucosal disease remission is regarded a key measure of treatment success as healing is associated with positive health outcomes. However, persistent villous atrophy is common, even after many years of a gluten‐free diet. As the clinical significance of asymptomatic enteropathy is uncertain the role for routine follow‐up biopsies remains contentious. Symptomatic non‐responsive coeliac disease is common and with systematic follow‐up a cause is usually found. Effective models of care involving the gastroenterologist, dietitian and primary care doctor will improve the consistency of long‐term management and likely translate into better patient outcomes. Identifying suitable treatment targets linked to long‐term health is an important goal.
Article
Full-text available
Over the last five decades the association between coeliac disease and other autoimmune disorders such as autoimmune thyroid disease or diabetes mellitus type 1 has been well established through many studies and to this day is subject to on-going clinical and scientific investigation worldwide. While no link has been established between celiac disease and type-2 diabetes mellitus, coeliac disease is common in patients with type 1 diabetes. The improvement of symptoms in patients with both conditions through dietary intervention, in the form of a gluten free diet, has been widely described within the literature. Our objectives were to review and synthesise the current knowledge on the nutritional treatment for patients with both conditions.
Article
Full-text available
Background: The relationship between the risk of celiac disease and both the age at which gluten is introduced to a child's diet and a child's early dietary pattern is unclear. Methods: We randomly assigned 832 newborns who had a first-degree relative with celiac disease to the introduction of dietary gluten at 6 months (group A) or 12 months (group B). The HLA genotype was determined at 15 months of age, and serologic screening for celiac disease was evaluated at 15, 24, and 36 months and at 5, 8, and 10 years. Patients with positive serologic findings underwent intestinal biopsies. The primary outcome was the prevalence of celiac disease autoimmunity and of overt celiac disease among the children at 5 years of age. Results: Of the 707 participants who remained in the trial at 36 months, 553 had a standard-risk or high-risk HLA genotype and completed the study. At 2 years of age, significantly higher proportions of children in group A than in group B had celiac disease autoimmunity (16% vs. 7%, P=0.002) and overt celiac disease (12% vs. 5%, P=0.01). At 5 years of age, the between-group differences were no longer significant for autoimmunity (21% in group A and 20% in group B, P=0.59) or overt disease (16% and 16%, P=0.78 by the log-rank test). At 10 years, the risk of celiac disease autoimmunity was far higher among children with high-risk HLA than among those with standard-risk HLA (38% vs. 19%, P=0.001), as was the risk of overt celiac disease (26% vs. 16%, P=0.05). Other variables, including breast-feeding, were not associated with the development of celiac disease. Conclusions: Neither the delayed introduction of gluten nor breast-feeding modified the risk of celiac disease among at-risk infants, although the later introduction of gluten was associated with a delayed onset of disease. A high-risk HLA genotype was an important predictor of disease. (Funded by the Fondazione Celiachia of the Italian Society for Celiac Disease; CELIPREV ClinicalTrials.gov number, NCT00639444.).
Article
Full-text available
A negative association between sleep duration and BMI has been observed in children. However, knowledge about the association between sleep duration and diet is limited. The objective was to examine the association between sleep duration and intake of foods and nutrients in children. In the present cross-sectional study, dietary intake and sleep duration were recorded by the parents for seven consecutive days in a food and sleep record in a representative sample of 802 4- to 14-year-old children. No sex differences were found regarding age and sleep duration. Sleep duration was negatively correlated to age (ρ = -0·68; P < 0·001) and BMI (ρ = -0·41; P < 0·001). In multiple linear regression analyses, sleep duration was not associated with energy intake (b = -0·015; P = 0·20), but there was a trend towards a positive association with intake of dietary fibre (b = 0·006; P = 0·05) and vegetables (b = 0·011; P = 0·05), and a negative association with intake of poultry (b = -0·002; P = 0·02), and a trend towards a negative association with intake of liquid 'discretionary calories' (b = -0·01; P = 0·05). Furthermore, in a comparison of dietary intake between age-dependent tertiles of sleep duration, only intake of liquid 'discretionary calories' was significantly lower in long sleepers than in short and medium sleepers (P = 0·03). In conclusion, sleep duration was not associated with energy intake and the proposal that children with short sleep duration have less healthy eating habits than children with longer sleep duration was only weakly supported by the present findings.
Article
Celiac sprue is a life-long inflammatory condition of the gastrointestinal tract that affects the small intestine in genetically susceptible individuals. The prevalence in Northern Europe is approximately 1:300, whereas in the United States it occurs less frequently. A small intestinal biopsy is mandatory to confirm the diagnosis. Treatment involves a strict gluten-free diet that excludes wheat, rye, and barley and that should be supervised by a dietician. Follow-up is important because of potential long-term complications.
Article
Seven patients (mean age, 37.6 years; 5 women) had several weeks of gluten sensitivity (GS)-like symptoms; 2 had flu-like symptom prodromes. The 7 cases had morphologically similar biopsy specimens; all tissue fragments had uniform injury-increased lymphoplasmacytic lamina propria inflammation, moderate to complete villous flattening, numerous crypt mitoses, and markedly increased villous intraepithelial lymphocytes (IELs). All patients were diagnosed with GS and prescribed a gluten free diet; all returned 9 to 38 weeks later questioning their diagnosis because symptoms had resolved substantially or completely. Clinical improvement was unrelated to gluten abstinence or ingestion. Repeated endoscopy and colonoscopy performed 4.1 to 16 months later showed normal mucosa in all 7 patients. Diseases other than GS can cause marked villous flattening and increased villous IELs in adults. The cause of small bowel mucosal injury is unknown. A similar nonGS-associated clinicopathologic complex, assumed to be due to a protracted viral enteritis or slow regression of a virus-induced immune reaction, occurs in children. The temporal aspects of symptom improvement and mucosal restitution in these 7 patients are similar to "acute self-limited colitis." An overly exuberant immune response to an infectious agent is possible.
Article
Kernels of the rye cultivars Danko and Halo were milled into white flour and compared with flour of the wheat cultivar Rektor. Flour proteins were extracted stepwise with a salt solution (albumins-globulins), 60% ethanol (prolamins), and 50% 2-propanol under reducing conditions (glutelins). The quantification by reversed-phase HPLC indicated that the extractable proteins of both rye flours consisted of ≈26% albuminsglobulins, 65% prolamins, and 9% glutelins. Compared with wheat flour, rye flours comprised significantly higher proportions of nonstorage proteins (albumins-globulins) and lower proportions of polymerized storage proteins (glutelins). SDS-PAGE revealed that the prolamin fractions of rye contained all four storage protein types (HMW, γ-75k, ω, and γ-40k secalins), whereas the glutelin fractions contained only HMW and γ-75k secalins. The quantification of secalin types by RP-HPLC showed a close relationship between the two cultivars. The γ-75k secalins contributed nearly half (≈46%) of the total storage proteins, followed by γ-40k secalins (24%) and ω secalins (17%); HMW secalins (≈7%) were minor components, and 6% of eluted proteins were not identified. The amino acid composition of γ-40k secalins corresponded to those of γ-gliadins of wheat, whereas γ-75k secalins were characterized by higher contents of glutamine and proline. Matrix-assisted laser desorption/ionization and time of flight mass spectrometry (MALDI-TOF MS) indicated molecular masses of about 52,000 (γ-75k) and 32,000 (γ-40k), respectively. Nterminal amino acid sequences were homologous with those of wheat γgliadins except for position 5 (asparagine in γ-75k and glutamine in γ-40k secalins) and position 12 (cysteine in γ-75k secalins). The N-terminal amino acid sequences of HMW and ω-secalins were homologous with those of the corresponding protein types of wheat. Gel-permeation HPLC of prolamin fractions revealed that rye flours contained a significantly higher proportion of ethanol-soluble oligomeric proteins than wheat flour.
Article
Background New evidence emerged on early feeding practices and the risk of coeliac disease.AimTo systematically update evidence on these practices to find out whether there is a need to revise current recommendations.MethodsMEDLINE, EMBASE and the Cochrane Library were searched from July 2012 (end of last search) to February 2015 for studies of any design that assessed the effect of gluten consumption and breastfeeding on the development of coeliac disease and/or coeliac disease-related autoimmunity.ResultsWe identified 21 publications, including two, new, large, randomised controlled trials performed in high-risk infants. Exclusive or any breastfeeding, as well as breastfeeding at the time of gluten introduction, did not reduce the risk of developing coeliac disease during childhood. For infants at high risk of developing coeliac disease, gluten introduction at 4 months of age in very small amounts, or at 6 or 12 months of age, resulted in similar rates of coeliac disease diagnosis in early childhood. Later gluten introduction was associated with later development of coeliac specific autoimmunity and coeliac disease during childhood, but not total risk reduction. Observational studies indicate that consumption of a higher amount of gluten at weaning may increase the risk for coeliac disease development.Conclusions Infant feeding practices (breastfeeding, time of gluten introduction) have no effect on the risk of developing coeliac disease during childhood (at least at specific timeframes evaluated in the included studies), necessitating an update of current European recommendations.
Article
Objective: To examine the seroprevalence, correlates, and characteristics of undetected coeliac disease in a large adult population sample in Cambridge, UK. Methods: The Cambridge General Practice Health Study invited individuals from 12 general practices, aged 45–76 years, to attend for a health survey that included a bone density measurement, between 1990 and 1995. A total of 7550 participants’ serum samples were tested for antiendomysial antibody (EMA). Seroprevalence of undetected coeliac disease was based on EMA positivity. Differences between EMA positive and negative participants of various physiological correlates and reported characteristics were estimated by multivariate logistic and linear regression and adjusted for age, sex, social class, and smoking behaviour. Results: The seroprevalence of undetected coeliac disease in this general population sample aged 45–76 was 1.2% (95% confidence interval (CI) 0.9–1.4). EMA positive participants (n=87) were on average slightly lighter by 2.2 kg (p=0.08), were more likely to have reported their general health as being “good or excellent” (odds ratio (OR) 1.76 (95% CI 0.90–3.46)), and were less likely to report being a current smoker (OR for current versus never 0.36 (95% CI 0.14–0.90)) than EMA negative participants. EMA positivity was associated with an 8% reduction in mean serum cholesterol (0.5 mmol/l; p<0.01) and reductions in mean haemoglobin (0.3 g/dl; p<0.01), total protein (1.0 g/l; p<0.05), and corrected serum calcium (0.02 mmol/l; p<0.05). There was an increased risk of osteoporosis in EMA positive participants (OR 3.1 (95% CI 1.3–7.2)) and of mild anaemia (OR 4.6 (95% CI 2.5–8.2)) compared with EMA negative participants. Conclusions: Undetected coeliac disease is likely to affect approximately 1% of the population of England aged 45–76 years, a value similar to several other countries. Those affected report “better health” but they do have an increased risk of osteoporosis and mild anaemia. In contrast, they have a favourable cardiovascular risk profile that may afford protection from ischaemic heart disease and stroke.
Article
Background: A window of opportunity has been suggested for reducing the risk of celiac disease by introducing gluten to infants at 4 to 6 months of age. Methods: We performed a multicenter, randomized, double-blind, placebo-controlled dietary-intervention study involving 944 children who were positive for HLA-DQ2 or HLA-DQ8 and had at least one first-degree relative with celiac disease. From 16 to 24 weeks of age, 475 participants received 100 mg of immunologically active gluten daily, and 469 received placebo. Anti-transglutaminase type 2 and antigliadin antibodies were periodically measured. The primary outcome was the frequency of biopsy-confirmed celiac disease at 3 years of age. Results: Celiac disease was confirmed by means of biopsies in 77 children. To avoid underestimation of the frequency of celiac disease, 3 additional children who received a diagnosis of celiac disease according to the 2012 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition diagnostic criteria (without having undergone biopsies) were included in the analyses (80 children; median age, 2.8 years; 59% were girls). The cumulative incidence of celiac disease among patients 3 years of age was 5.2% (95% confidence interval [CI], 3.6 to 6.8), with similar rates in the gluten group and the placebo group (5.9% [95% CI, 3.7 to 8.1] and 4.5% [95% CI, 2.5 to 6.5], respectively; hazard ratio in the gluten group, 1.23; 95% CI, 0.79 to 1.91). Rates of elevated levels of anti-transglutaminase type 2 and antigliadin antibodies were also similar in the two study groups (7.0% [95% CI, 4.7 to 9.4] in the gluten group and 5.7% [95% CI, 3.5 to 7.9] in the placebo group; hazard ratio, 1.14; 95% CI, 0.76 to 1.73). Breast-feeding, regardless of whether it was exclusive or whether it was ongoing during gluten introduction, did not significantly influence the development of celiac disease or the effect of the intervention. Conclusions: As compared with placebo, the introduction of small quantities of gluten at 16 to 24 weeks of age did not reduce the risk of celiac disease by 3 years of age in this group of high-risk children. (Funded by the European Commission and others; PreventCD Current Controlled Trials number, ISRCTN74582487.).